ChiCTR2100050400
Untitled Trial
A prospective, single center, single arm, phase II clinical study of maintenance therapy with chidamide after allogeneic hematopoietic stem cell transplantation (allo HSCT) for high risk acute myeloid leukemia (HR AML)
Aerospace Center Hospital·Phase 2·Chinese Clinical Trial RegistryRecruiting
View on Chinese Clinical Trial Registry →Study focus
- Disease/Condition
- Leukemia
Sponsor & location
- Primary sponsor
- Aerospace Center Hospital
- Funder
- Self funded
- Location
- China
Timeline & enrollment
- Phase
- Phase 2
- Start date
- N/A
- End date
- Dec 31, 2023
ICD-10 classifications
Leukaemia, unspecifiedMyeloid leukaemiaMyeloid leukaemia, unspecifiedOther myeloid leukaemiaMonocytic leukaemia, unspecified
Data source
- Registry
- Chinese Clinical Trial Registry
- Trial ID
- ChiCTR2100050400
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for ChiCTR2100050400 through Pure Global AI's free database. This Phase 2 trial is sponsored by Aerospace Center Hospital and is currently Recruiting. The study focuses on Leukemia.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Chinese Clinical Trial Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.